- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
ALBIO
PAR
Week ended 07 Aug 2026
Weekly Investor Report
Biosynex SA · Healthcare · Medical Devices
Latest close
0.90 EUR
-1.7%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -0.4% below the Trend Line and sits at 40.3% of its 52-week range. The latest completed week returned -1.7%, after a 2.0% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
29
out of 100
Latest Close
0.90 EUR
7 Aug 2026
1W Return
-1.7%
latest completed week
4W Return
2.0%
short-term follow-through
12W Return
-7.4%
quarterly tape
Trend Breadth
36.5%
19 of 52 weeks active
Volume Ratio
0.1x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.7%
Latest completed week; four-week move 2.0%.
Indicator stack
20/20
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 32.63%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -0.4% below the Trend Line and sits at 40.3% of its 52-week range. The latest completed week returned -1.7%, after a 2.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3712-week average 0.40
12-week confirmation
Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership7/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.37Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.0% over four weeks, -7.4% over 12 weeks, and -25.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year19
Trend breadth36.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.21Latest activity-pressure read.
Pressure change-333.0%Four-week change in activity pressure.
Leadership0.39Latest relative-leadership reading.
RS change137.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-42.4%Distance below the 52-week high.
13-week volatility4.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2615 weeks finished lower.
Best week+35.8%Week of 8 May.
Worst week-11.4%Week of 5 Jun.
Latest week-1.7%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains7
Flat weeks1
Modest losses9
Sharp losses6
Recent vol4.8%13-week weekly-return volatility.
Base vol11.2%52-week weekly-return volatility.
Up/down split21/29Count of positive and negative weeks in the 52-week window.
Average skew7.8% / -5.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFR Healthcare
4-week rank28 / 76
Group average0.7%
Trend breadth26.3%
Trend26.3%active weekly trend signals
MD40.8%positive activity pressure
RS19.7%positive relative leadership
Four-week leaders
IndustryFR Medical Devices
4-week rank5 / 13
Group average-5.4%
Trend breadth15.4%
Trend15.4%active weekly trend signals
MD15.4%positive activity pressure
RS15.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape27/100
Trend, activity pressure, participation, and risk combine to a 27/100 tape read.
Indicator analysis58/100Latest 12-week confirmation: trend 11/12, activity pressure 5/12, relative leadership 7/12.
Activity pressure 0.37; No reversal markers Next-Week ExpectancyNegative 32.63%Next-week expectancy is negative with a 32.63% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.90 EUR | -1.7% | 0.91 EUR | 3.22 EUR | -0.21 | 0.39 | 25.2K | Off |
| 31 Jul 2026 | 0.92 EUR | 0.0% | 0.90 EUR | 3.28 EUR | -0.18 | 3.59 | 18.3K | On |
| 24 Jul 2026 | 0.92 EUR | 3.1% | 0.89 EUR | 3.35 EUR | -0.14 | 4.26 | 42.6K | On |
| 17 Jul 2026 | 0.89 EUR | 0.7% | 0.87 EUR | 3.41 EUR | -0.10 | 0.65 | 25.4K | On |
| 10 Jul 2026 | 0.89 EUR | -1.3% | 0.86 EUR | 3.47 EUR | -0.05 | -1.03 | 54.1K | On |
| 3 Jul 2026 | 0.90 EUR | 0.4% | 0.85 EUR | 3.53 EUR | -0.03 | -2.66 | 3.2K | On |
| 26 Jun 2026 | 0.89 EUR | 0.9% | 0.84 EUR | 3.59 EUR | -0.02 | -2.63 | 16.6K | On |
| 19 Jun 2026 | 0.89 EUR | -2.6% | 0.82 EUR | 3.64 EUR | 0.09 | -4.74 | 1.5K | On |
| 12 Jun 2026 | 0.91 EUR | -2.2% | 0.81 EUR | 3.70 EUR | 0.23 | -2.35 | 8.6K | On |
| 5 Jun 2026 | 0.93 EUR | -11.4% | 0.80 EUR | 3.76 EUR | 0.37 | 0.41 | 5.2K | On |
| 29 May 2026 | 1.05 EUR | 1.4% | 0.79 EUR | 3.81 EUR | 0.56 | 12.86 | 271.5K | On |
| 22 May 2026 | 1.03 EUR | 6.0% | 0.77 EUR | 3.86 EUR | 0.34 | 11.43 | 552.2K | On |
| 15 May 2026 | 0.98 EUR | -11.3% | 0.76 EUR | 3.91 EUR | 0.17 | 6.51 | 2.0M | On |
| 8 May 2026 | 1.10 EUR | 35.8% | 0.75 EUR | 3.97 EUR | 0.04 | 17.00 | 481.0K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.